Search Results 1171-1180 of 19352 for hemoglobin

1. Study Evaluating the Antitumor Activity and Safety of Niraparib as Neoadjuvant Treatment - Mayo Clinic

   Hemoglobin ≥9 g/dL;; Serum creatinine ≤1.5 x upper limit of normal (ULN) or calculated creatinine clearance ≥50 mL/min using Cockcroft-Gault equation ...

2. A Study in Treating Patients With Kidney Cancer Undergoing Nephrectomy Comparing PERioperative Nivolumab vs. Observation - Mayo Clinic

   Hemoglobin >= 9.0 g/dL, within 4 weeks of randomization. Serum creatinine =< 1.5 x upper limit of normal (ULN) or calculated creatinine clearance (CrCl) ...

3. Study of Determine the Safety and Effectiveness of SHP647 as Maintenance Therapy in Subjects with Moderate-to-Severe Crohn's Disease - Mayo Clinic

   Hemoglobin level ≤ 80 g/L (8.0 g/dL);; Platelet count ≤ 100 × 109/L (100,000 cells/mm^3) or ≥ 1000 × 109/L (1,000,000 cells/mm^3)*;; White blood cell count ...

4. Low-Dose or High-Dose Lenalidomide in Treating Children with Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma - Mayo Clinic

   Hemoglobin ≥ 8.0 g/dL (may receive red blood cell [RBC] transfusions); Creatinine clearance or radioisotope glomerular filtration rate(GFR) ≥ 70 mL/min/m^2 ...

5. A Study of AG-946 in Participants With Anemia Due to Lower-Risk Myelodysplastic Syndromes (LR-MDS) - Mayo Clinic

   A hemoglobin (Hb) concentration \<11.0 grams per deciliter (g/dL) during the 4-week Screening Period; 5. Eastern Cooperative Oncology Group (ECOG) ...

6. Combination Chemotherapy Followed by Peripheral Stem Cell Transplant in Treating Young Patients with Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma - Mayo Clinic

   Hemoglobin > 8 g/dL (RBC transfusions allowed); Prior corticosteroids allowed; No prior radiation therapy or chemotherapy. Participating Mayo Clinic locations.

7. Renal Optimization Strategies Evaluation in Acute Heart Failure and Reliable Evaluation of Dyspnea in the Heart Failure Network (ROSE) Study - Mayo Clinic

   Hemoglobin (Hgb) < 9 g/dl; Renal replacement therapy; History of renal artery stenosis > 50%; Hemodynamically significant arrhythmias including ventricular ...

8. RLY-2608-201-Ph2 Study Of RLY-2608 In PROS And PIK3CA Driven Malformations - Mayo Clinic

   Hemoglobin ≥ 9 g/dL (red blood cell transfusion and erythropoietin may be used to reach 9 g/dL but must have been administered at least 2 weeks prior to ...

9. Benzocaine (oral route, oromucosal route) - Side effects & dosage - Mayo Clinic

   Hereditary metabolic disorder affecting red blood cells (eg, G6PD deficiency, hemoglobin-M disease, NADH-methemoglobin reductase deficiency, pyruvate-kinase ...

10. CD-NP (Cenderitide) Therapy for the Preservation of Left Ventricular Function Post Anterior Myocardial Infarction - Pilot Study - Mayo Clinic

    Hemoglobin < 8.5 gm/dl; Other acute or chronic medical conditions or laboratory abnormality which may increase the risks associated with study participation ...